Literature DB >> 15051748

Epidemiology of diabetes.

Nathaniel Winer1, James R Sowers.   

Abstract

The incidence of diabetes mellitus, particularly type 2 diabetes, is increasing dramatically in the United States and in other Westernized, industrialized societies because of increasing obesity, sedentary lifestyle, and population aging. There are currently 20 million persons with diabetes in the United States, of whom more than 5 million remain undiagnosed. The diabetic population consumes a disproportionate share of health care resources because of both microvascular and macrovascular complications. Diabetes is a major cause of new-onset blindness, end-stage renal disease, and nontraumatic amputation in the United States. Cardiovascular disease accounts for up to 80% of premature excess mortality in diabetic patients. Strategies to lessen the disease burden in these patients include hygienic measures (diet and exercise) as well as rigorous treatment of hypertension, dyslipidemia, and hyperglycemia.

Entities:  

Mesh:

Year:  2004        PMID: 15051748     DOI: 10.1177/0091270004263017

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  54 in total

Review 1.  Nutrition and pregnancy: the link between dietary intake and diabetes.

Authors:  Lois Jovanovic
Journal:  Curr Diab Rep       Date:  2004-08       Impact factor: 4.810

2.  Identification of microRNA biomarkers in type 2 diabetes: a meta-analysis of controlled profiling studies.

Authors:  Hongmei Zhu; Siu Wai Leung
Journal:  Diabetologia       Date:  2015-02-13       Impact factor: 10.122

3.  Effect of the PPARγ C161T gene variant on serum lipids in ischemic stroke patients with and without type 2 diabetes mellitus.

Authors:  Khouloud Chehaibi; Samir Nouira; Kacem Mahdouani; Sonia Hamdi; Mustapha Rouis; Mohamed Naceur Slimane
Journal:  J Mol Neurosci       Date:  2014-05-21       Impact factor: 3.444

4.  Use of antidepressants and the risk of type 2 diabetes mellitus: a nested case-control study.

Authors:  Star Khoza; Jamie C Barner; Thomas M Bohman; Karen Rascati; Kenneth Lawson; James P Wilson
Journal:  Int J Clin Pharm       Date:  2012-01-18

Review 5.  Octreotide's role in the management of sulfonylurea-induced hypoglycemia.

Authors:  Patrick P Dougherty; Wendy Klein-Schwartz
Journal:  J Med Toxicol       Date:  2010-06

6.  Diabetes mellitus in individuals with spinal cord injury or disorder.

Authors:  Sherri L Lavela; Frances M Weaver; Barry Goldstein; Ke Chen; Scott Miskevics; Suparna Rajan; David R Gater
Journal:  J Spinal Cord Med       Date:  2006       Impact factor: 1.985

7.  Increased blood-brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases.

Authors:  B T Hawkins; T F Lundeen; K M Norwood; H L Brooks; R D Egleton
Journal:  Diabetologia       Date:  2006-12-02       Impact factor: 10.122

8.  Diabetes in sub-saharan Africa: kenya, mali, mozambique, Nigeria, South Africa and zambia.

Authors:  Mario Azevedo; Sridevi Alla
Journal:  Int J Diabetes Dev Ctries       Date:  2008-10

9.  PPARgamma gene C161T substitution alters lipid profile in Chinese patients with coronary artery disease and type 2 diabetes mellitus.

Authors:  Jing Wan; Shixi Xiong; Shengping Chao; Jianming Xiao; Yexin Ma; Jinghua Wang; Sabita Roy
Journal:  Cardiovasc Diabetol       Date:  2010-03-24       Impact factor: 9.951

10.  Blood pressure-lowering effect of nebivolol in hypertensive patients with type 2 diabetes mellitus: the YESTONO study.

Authors:  Andre C Schmidt; Christine Graf; Klara Brixius; Juergen Scholze
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.